about
The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America.Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancyDelivery of epilepsy care to adults with intellectual and developmental disabilities.Cardiopulmonary complications during pediatric seizures: a prelude to understanding SUDEP.Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis.MRI findings in pediatric ophthalmoplegic migraine: a case report and literature review.Usefulness of ocular compression during electroencephalography in distinguishing breath-holding spells and syncope from epileptic seizures.Treatment of drop attacks in Coffin-Lowry syndrome with the use of sodium oxybate.Clinical reasoning: a teenage girl with excessive daytime sleepiness, "fainting spells," and dream mentations."Nocturnal seizures" in idiopathic pulmonary arterial hypertension.Advantages of respiratory monitoring during video-EEG evaluation to differentiate epileptic seizures from other events.Sleep patterns in pediatric sickle cell disease.SLC25A22 is a novel gene for migrating partial seizures in infancy.Risk factors associated with death in in-hospital pediatric convulsive status epilepticus.Fall-prevention policies in pediatric sleep laboratories.Quality measures for the care of pediatric patients with obstructive sleep apnea.Copy number variation plays an important role in clinical epilepsy.Teaching NeuroImages: NMDA encephalomyelitis with MRI abnormalities isolated to ventral spinal cord gray matterEarly thalamic lesions in patients with sleep-potentiated epileptiform activity.An uncommon case of pediatric neurobrucellosis associated with intracranial hypertensionPRO: "Not just little adults": AASM should require pediatric accreditation for integrated sleep medicine programs serving both children (0-16 years) and adults.Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.Oxcarbazepine therapy in very young children: a single-center clinical experience.Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.Restless Legs Syndrome in Pediatric Patients With Nephrotic Syndrome.Epileptic seizures in the pediatric intensive care unit setting.The adverse effects of antiepileptic drugs in children.Vagus nerve stimulation in children with refractory epilepsy: unusual complications and relationship to sleep-disordered breathing.The role of phenytoin in the treatment of localization related epilepsy: an international internet-based survey of neurologists and epileptologists.Narcolepsy in children: a single-center clinical experience.The clinical and laboratory assessment of the sleepy child.Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma.Insomnia of childhood.Narcolepsy and other hypersomnias in children.Sleep and epilepsy in children and adolescents.New onset epilepsy in Prader-Willi syndrome: semiology and literature review.Restless legs syndrome and periodic limb movements disorder in the pediatric population.Epileptic and nonepileptic paroxysmal events out of sleep in children.Chronobiology of epilepsy: diagnostic and therapeutic implications of chrono-epileptology.
P50
Q27312713-D7B9E018-9480-4185-AC76-0A70A7CC789EQ28268653-6AB3A600-B89B-4887-95A6-BACDAB20F5FAQ30671535-40E3806B-A41A-449C-8608-530E7E68E311Q30838358-034C99E7-854C-45A8-AEF3-B021DDF9378BQ30997796-577E4AEC-70E9-4879-A573-B108DAD01ADDQ31118825-14FB39A2-B1FA-476A-BB69-288670B7700EQ33154308-DEE9D078-4CEB-4836-98A8-CA15C9306EF8Q33155619-339383F0-E325-4928-90F7-FB9B5543E910Q33158789-F0E0DA41-5002-420C-804E-C91E9DAE5E66Q33163402-F92F42E1-EAC8-47D2-A835-3CE03C2ED676Q33631295-86D25FCD-2C22-4394-B478-6B45E9032287Q33640565-AEC48DFD-1905-40B2-9FEB-38F93679B992Q33651270-1ABF2D3E-DCDD-4D3B-BB17-C8268A137574Q34460437-332943E9-28C9-4B7C-94BE-0B004E898C38Q34585336-6A1333E2-63D4-4175-ABA0-F8C7EBB75CCCQ35138210-029188EA-8A0B-489C-AC2D-6C0A493F4D2AQ35804664-645C72C1-AB03-4939-9101-FA798638E876Q35966459-53C5D127-65EC-4CF2-8A4F-694045EC1F16Q35985976-EBD12A50-0939-45B0-87F2-715BE77F61D0Q36147942-41F39D5C-781A-4F22-9367-0963875D801AQ36282411-C3137485-780C-4E2B-B48E-5EAFBD3763CBQ36305014-BDF5F2AC-3244-42C4-B676-E151E3A2263DQ36463922-6EF200E5-E582-4BFD-A41E-B8CF82F6ADEBQ36580983-67239C41-CE78-4521-B0A3-69F77CF7DB28Q36601493-FF8FA744-2FFE-439D-8B58-FE1116A20573Q36668727-7B6D345D-CA53-412E-B28E-1D0342741B8AQ36675778-37B4E9B0-6981-4E71-B2FE-E00542BF2408Q36811532-8E075BFC-C822-45D2-98E1-BFC1A4DF65C5Q36874252-5A24C66C-C8CB-4C20-BCD4-DB052959EA26Q37018882-40196939-0B5A-4E51-9499-3E579AE6C8F9Q37138133-F41B0780-28F7-4372-8D43-236B15D963F8Q37191642-9870DC77-25F8-4641-ADB1-D4283C694FFBQ37273563-069CEED4-AAB7-4DFD-94A1-6687FE9D69F3Q37324148-F5CC9EFC-BD5B-4542-AF38-8EE698F2FAABQ37331418-688CB24D-1030-4D24-8551-49C29E4C6053Q37771555-579AE4AD-2ACA-4DCC-A0F0-5389E29FD206Q37788402-65F3F18F-8A87-485C-8186-0C24F24F2175Q37790965-B5DB87FC-9548-4788-B856-416568A31A0EQ37852550-53B1B972-2DD4-46C5-9232-DDEE0E1041A8Q37852554-9D2C9945-3572-453F-B602-55B5F86406BB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Sanjeev V Kothare
@ast
Sanjeev V Kothare
@en
Sanjeev V Kothare
@es
Sanjeev V Kothare
@nl
Sanjeev V Kothare
@sl
type
label
Sanjeev V Kothare
@ast
Sanjeev V Kothare
@en
Sanjeev V Kothare
@es
Sanjeev V Kothare
@nl
Sanjeev V Kothare
@sl
prefLabel
Sanjeev V Kothare
@ast
Sanjeev V Kothare
@en
Sanjeev V Kothare
@es
Sanjeev V Kothare
@nl
Sanjeev V Kothare
@sl
P214
P244
P106
P21
P214
P244
n2010184462
P31
P496
0000-0001-7849-6649
P7859
lccn-n2010184462